Treatment goals in ovarian cancer
- 1 May 2005
- journal article
- review article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 15 (s1) , 3-11
- https://doi.org/10.1111/j.1525-1438.2005.15351.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?Journal of Clinical Oncology, 2004
- Attitudes to chemotherapy in patients with ovarian cancerGynecologic Oncology, 2004
- Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care ClinicsJAMA, 2004
- Maintenance Therapy in Advanced Ovarian Cancer: Progression-Free Survival and Clinical BenefitJournal of Clinical Oncology, 2003
- International Collaborative Ovarian Neoplasm Trial 1: A Randomized Trial of Adjuvant Chemotherapy in Women With Early-Stage Ovarian CancerJNCI Journal of the National Cancer Institute, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaThe Lancet, 2001
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996